Skip to main content

J&J Broke Into A Sprint To Test Talcum Powder After Recall

J&J Broke Into A Sprint To Test Talcum Powder After Recall

J&J Broke Into A Sprint To Test Talcum Powder After Recall

Introduction

Johnson & Johnson (J&J) announced that they did not find any marks of contamination in their talcum powder during an independent testing done just 11 days after the U.S. Food and Drug Administration (FDA) warning.

The Pennsylvania laboratory where the tests were conducted discovered some amounts of asbestos in several baby powder samples, which was considered useless as the air conditioner at the lab was found to be contaminated. The follow-up tests conducted at the lab did not show any trace of asbestos.

Last month, J&J announced a voluntary recall of a single batch of its baby powder after receiving a warning from the FDA. The recall, applied to lot #22318RB, affected 33,000 bottles of talcum powder.

Nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits are consolidated under multidistrict litigation MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation. Lawsuits are also pending in a coordinated California proceeding under Judicial Council Coordinated Proceeding No. 4877.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!